Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2016
Price : $35 *
At a glance
- Drugs BI 1060469 (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 11 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Nov 2014 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 21 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.